Please assess the completion status of the following clinical trial:

Trial Title: Safety And Efficacy Of GSK233705 Plus Salmeterol Compared With 2 Active Comparators And Placebo In Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE2
- Number of Arms: None

Eligibility Criteria:
Inclusion criteria:~* females of non-childbearing potential or postmenopausal;~* history of COPD as defined by ATS/ERS criteria;~* moderate COPD responsive to ipratropium and salbutamol;~* current smoker or ex-smoker.~Exclusion criteria:~* no instable COPD; max 1000 mcg inhaled steroids per day; no B-blockers

- Gender: ALL
- Minimum Age: 40 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).